|
| 37657710 | A semi-automated pipeline for quantifying drusen-like deposits in human induced pluripotent stem cell-derived retinal pigment epithelium cells. | SLAS Technol | 2024 |
| 37657710 | A semi-automated pipeline for quantifying drusen-like deposits in human induced pluripotent stem cell-derived retinal pigment epithelium cells. | SLAS Technol | 2024 |
| 36693952 | The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer. | Oncogene | 2023 |
| 37771787 | A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to <sup>177</sup>Lutetium-DOTA-octreotate radionuclide therapy. | Theranostics | 2023 |
| 37072858 | COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. | J Exp Clin Cancer Res | 2023 |
| 37191437 | Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia. | Cancer Discov | 2023 |
| 37188266 | Radiation therapy attenuates lymphatic vessel repair by reducing VEGFR-3 signalling. | Front Pharmacol | 2023 |
| 36693952 | The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer. | Oncogene | 2023 |
| 37371546 | Using a Quantitative High-Throughput Screening Platform to Identify Molecular Targets and Compounds as Repurposing Candidates for Endometriosis. | Biomolecules | 2023 |
| 37355554 | MAC-Seq: Coupling Low-Cost, High-Throughput RNA-Seq with Image-Based Phenotypic Screening in 2D and 3D Cell Models. | Methods Mol Biol | 2023 |
| 37771787 | A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to <sup>177</sup>Lutetium-DOTA-octreotate radionuclide therapy. | Theranostics | 2023 |
| 37191437 | Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia. | Cancer Discov | 2023 |
| 37188266 | Radiation therapy attenuates lymphatic vessel repair by reducing VEGFR-3 signalling. | Front Pharmacol | 2023 |
| 37371546 | Using a Quantitative High-Throughput Screening Platform to Identify Molecular Targets and Compounds as Repurposing Candidates for Endometriosis. | Biomolecules | 2023 |
| 37072858 | COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. | J Exp Clin Cancer Res | 2023 |
| 37355554 | MAC-Seq: Coupling Low-Cost, High-Throughput RNA-Seq with Image-Based Phenotypic Screening in 2D and 3D Cell Models. | Methods Mol Biol | 2023 |
| 34464972 | Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutation. | Blood Adv | 2022 |
| 36103522 | Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. | Sci Adv | 2022 |
| 35831623 | Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysis. | Cell Death Differ | 2022 |
| 35810535 | Hit-to-lead optimization of novel phenyl imidazole carboxamides that are active against Leishmania donovani. | Eur J Med Chem | 2022 |
| 36189423 | Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells. | Mol Ther Nucleic Acids | 2022 |
| 36923279 | Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer. | Cancer Res Commun | 2022 |
| 34464972 | Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutation. | Blood Adv | 2022 |
| 35232962 | Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanoma. | Nat Commun | 2022 |
| 34998954 | miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma. | Mol Ther | 2022 |
| 35831623 | Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysis. | Cell Death Differ | 2022 |
| 35810535 | Hit-to-lead optimization of novel phenyl imidazole carboxamides that are active against Leishmania donovani. | Eur J Med Chem | 2022 |
| 36923279 | Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer. | Cancer Res Commun | 2022 |
| 36103522 | Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. | Sci Adv | 2022 |
| 36189423 | Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells. | Mol Ther Nucleic Acids | 2022 |
| 34998954 | miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma. | Mol Ther | 2022 |
| 35232962 | Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanoma. | Nat Commun | 2022 |
| 32768338 | Loss of HPV type 16 E7 restores cGAS-STING responses in human papilloma virus-positive oropharyngeal squamous cell carcinomas cells. | J Microbiol Immunol Infect | 2021 |
| 34111999 | High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids. | SLAS Discov | 2021 |
| 34004147 | The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer. | Cell | 2021 |
| 34050191 | High-content siRNA 3D co-cultures to identify myoepithelial cell-derived breast cancer suppressor proteins. | Sci Data | 2021 |
| 34041837 | Genome-wide genetic screen identifies host ubiquitination as important for Legionella pneumophila Dot/Icm effector translocation. | Cell Microbiol | 2021 |
| 34315763 | SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation Status. | Mol Cancer Ther | 2021 |
| 32768338 | Loss of HPV type 16 E7 restores cGAS-STING responses in human papilloma virus-positive oropharyngeal squamous cell carcinomas cells. | J Microbiol Immunol Infect | 2021 |
| 33314700 | A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death. | EMBO Mol Med | 2021 |
| 33173151 | The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer. | Br J Cancer | 2021 |
| 34413130 | CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition. | Mol Cancer Ther | 2021 |
| 34413130 | CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition. | Mol Cancer Ther | 2021 |
| 34041837 | Genome-wide genetic screen identifies host ubiquitination as important for Legionella pneumophila Dot/Icm effector translocation. | Cell Microbiol | 2021 |
| 34315763 | SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation Status. | Mol Cancer Ther | 2021 |
| 34004147 | The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer. | Cell | 2021 |
| 34111999 | High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids. | SLAS Discov | 2021 |
| 34050191 | High-content siRNA 3D co-cultures to identify myoepithelial cell-derived breast cancer suppressor proteins. | Sci Data | 2021 |
| 33314700 | A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death. | EMBO Mol Med | 2021 |
| 33173151 | The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer. | Br J Cancer | 2021 |